Last 12 months
Inside the activity.
10 purchase rows · 139 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 4 |
| Feb 2026 | 4 | 9 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 26 |
| May 2026 | 0 | 54 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 5 | 44 |
| Aug 2026 | 1 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 06, 2026 Filed May 7, 2026 00:15 UTC |
Foff Erin PennockChief Medical Officer
|
SaleVoting Common Stock | 8,152 | $28.04 | $228,582.08 |
DisclosureSEC source: 0002021233-26-000008 · form4-05062026_080507.xml · nonDerivative · entry 7 Foff Erin Pennock · CIK 0002021233 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 366,397 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.675 to $28.6587 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 06, 2026 Filed May 7, 2026 00:15 UTC |
Kroeger Christopher A.Director · Chief Executive Officer
|
SaleVoting Common Stock | 15,603 | $29.13 | $454,515.39 |
DisclosureSEC source: 0001658918-26-000008 · form4-05062026_080501.xml · nonDerivative · entry 8 Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,580,820 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.71 to $29.57 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 06, 2026 Filed May 7, 2026 00:15 UTC |
Kroeger Christopher A.Director · Chief Executive Officer
|
SaleVoting Common Stock | 8,098 | $28.04 | $227,067.92 |
DisclosureSEC source: 0001658918-26-000008 · form4-05062026_080501.xml · nonDerivative · entry 7 Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,596,423 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.675 to $28.6587 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 06, 2026 Filed May 7, 2026 00:15 UTC |
Lillie James WoodruffChief Scientific Officer
|
SaleVoting Common Stock | 16,421 | $29.13 | $478,343.73 |
DisclosureSEC source: 0001728746-26-000008 · form4-05062026_080505.xml · nonDerivative · entry 8 Lillie James Woodruff · CIK 0001728746 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 243,450 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.71 to $29.57 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 06, 2026 Filed May 7, 2026 00:15 UTC |
Lillie James WoodruffChief Scientific Officer
|
SaleVoting Common Stock | 8,390 | $28.04 | $235,255.60 |
DisclosureSEC source: 0001728746-26-000008 · form4-05062026_080505.xml · nonDerivative · entry 7 Lillie James Woodruff · CIK 0001728746 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 259,871 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.675 to $28.6587 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 05, 2026 Filed May 7, 2026 00:15 UTC |
Setia VishwasChief Financial Officer
|
SaleVoting Common Stock | 968 | $29.00 | $28,072.00 |
DisclosureSEC source: 0002021256-26-000008 · form4-05062026_080509.xml · nonDerivative · entry 6 Setia Vishwas · CIK 0002021256 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 366,820 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.79 to $29.26 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 05, 2026 Filed May 7, 2026 00:15 UTC |
Setia VishwasChief Financial Officer
|
SaleVoting Common Stock | 9,935 | $28.12 | $279,372.20 |
DisclosureSEC source: 0002021256-26-000008 · form4-05062026_080509.xml · nonDerivative · entry 5 Setia Vishwas · CIK 0002021256 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 367,788 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.755 to $28.75 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 05, 2026 Filed May 7, 2026 00:15 UTC |
Foff Erin PennockChief Medical Officer
|
SaleVoting Common Stock | 931 | $29.00 | $26,999.00 |
DisclosureSEC source: 0002021233-26-000008 · form4-05062026_080507.xml · nonDerivative · entry 6 Foff Erin Pennock · CIK 0002021233 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 374,549 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.80 to $29.26 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 05, 2026 Filed May 7, 2026 00:15 UTC |
Foff Erin PennockChief Medical Officer
|
SaleVoting Common Stock | 9,645 | $28.12 | $271,217.40 |
DisclosureSEC source: 0002021233-26-000008 · form4-05062026_080507.xml · nonDerivative · entry 5 Foff Erin Pennock · CIK 0002021233 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 375,480 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.755 to $28.75 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 05, 2026 Filed May 7, 2026 00:15 UTC |
Kroeger Christopher A.Director · Chief Executive Officer
|
SaleVoting Common Stock | 928 | $29.00 | $26,912.00 |
DisclosureSEC source: 0001658918-26-000008 · form4-05062026_080501.xml · nonDerivative · entry 6 Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,604,521 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.80 to $29.26 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 05, 2026 Filed May 7, 2026 00:15 UTC |
Kroeger Christopher A.Director · Chief Executive Officer
|
SaleVoting Common Stock | 9,544 | $28.12 | $268,377.28 |
DisclosureSEC source: 0001658918-26-000008 · form4-05062026_080501.xml · nonDerivative · entry 5 Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,605,449 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.755 to $28.75 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 05, 2026 Filed May 7, 2026 00:15 UTC |
Lillie James WoodruffChief Scientific Officer
|
SaleVoting Common Stock | 963 | $29.00 | $27,927.00 |
DisclosureSEC source: 0001728746-26-000008 · form4-05062026_080505.xml · nonDerivative · entry 6 Lillie James Woodruff · CIK 0001728746 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 268,261 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.79 to $29.25 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 05, 2026 Filed May 7, 2026 00:15 UTC |
Lillie James WoodruffChief Scientific Officer
|
SaleVoting Common Stock | 10,132 | $28.12 | $284,911.84 |
DisclosureSEC source: 0001728746-26-000008 · form4-05062026_080505.xml · nonDerivative · entry 5 Lillie James Woodruff · CIK 0001728746 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 269,224 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.755 to $28.75 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 04, 2026 Filed May 7, 2026 00:15 UTC |
Setia VishwasChief Financial Officer
|
SaleVoting Common Stock | 787 | $30.12 | $23,704.44 |
DisclosureSEC source: 0002021256-26-000008 · form4-05062026_080509.xml · nonDerivative · entry 4 Setia Vishwas · CIK 0002021256 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 377,723 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.55 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 04, 2026 Filed May 7, 2026 00:15 UTC |
Setia VishwasChief Financial Officer
|
SaleVoting Common Stock | 325 | $29.56 | $9,607.00 |
DisclosureSEC source: 0002021256-26-000008 · form4-05062026_080509.xml · nonDerivative · entry 3 Setia Vishwas · CIK 0002021256 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 378,510 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.9669 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 04, 2026 Filed May 7, 2026 00:15 UTC |
Setia VishwasChief Financial Officer
|
SaleVoting Common Stock | 8,989 | $28.28 | $254,208.92 |
DisclosureSEC source: 0002021256-26-000008 · form4-05062026_080509.xml · nonDerivative · entry 2 Setia Vishwas · CIK 0002021256 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 378,835 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.845 to $28.74 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 04, 2026 Filed May 7, 2026 00:15 UTC |
Setia VishwasChief Financial Officer
|
SaleVoting Common Stock | 4,803 | $27.36 | $131,410.08 |
DisclosureSEC source: 0002021256-26-000008 · form4-05062026_080509.xml · nonDerivative · entry 1 Setia Vishwas · CIK 0002021256 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 387,824 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.84 to $27.835 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 04, 2026 Filed May 7, 2026 00:15 UTC |
Foff Erin PennockChief Medical Officer
|
SaleVoting Common Stock | 700 | $30.08 | $21,056.00 |
DisclosureSEC source: 0002021233-26-000008 · form4-05062026_080507.xml · nonDerivative · entry 4 Foff Erin Pennock · CIK 0002021233 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 385,125 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.55 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 04, 2026 Filed May 7, 2026 00:15 UTC |
Foff Erin PennockChief Medical Officer
|
SaleVoting Common Stock | 312 | $29.56 | $9,222.72 |
DisclosureSEC source: 0002021233-26-000008 · form4-05062026_080507.xml · nonDerivative · entry 3 Foff Erin Pennock · CIK 0002021233 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 385,825 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.9669 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 04, 2026 Filed May 7, 2026 00:15 UTC |
Foff Erin PennockChief Medical Officer
|
SaleVoting Common Stock | 5,460 | $28.37 | $154,900.20 |
DisclosureSEC source: 0002021233-26-000008 · form4-05062026_080507.xml · nonDerivative · entry 2 Foff Erin Pennock · CIK 0002021233 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 386,137 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.845 to $28.73 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 04, 2026 Filed May 7, 2026 00:15 UTC |
Foff Erin PennockChief Medical Officer
|
SaleVoting Common Stock | 9,180 | $27.50 | $252,450.00 |
DisclosureSEC source: 0002021233-26-000008 · form4-05062026_080507.xml · nonDerivative · entry 1 Foff Erin Pennock · CIK 0002021233 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 391,597 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.84 to $27.835 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 04, 2026 Filed May 7, 2026 00:15 UTC |
Kroeger Christopher A.Director · Chief Executive Officer
|
SaleVoting Common Stock | 697 | $30.08 | $20,965.76 |
DisclosureSEC source: 0001658918-26-000008 · form4-05062026_080501.xml · nonDerivative · entry 4 Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,614,993 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.55 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 04, 2026 Filed May 7, 2026 00:15 UTC |
Kroeger Christopher A.Director · Chief Executive Officer
|
SaleVoting Common Stock | 311 | $29.56 | $9,193.16 |
DisclosureSEC source: 0001658918-26-000008 · form4-05062026_080501.xml · nonDerivative · entry 3 Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,615,690 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.9669 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 04, 2026 Filed May 7, 2026 00:15 UTC |
Kroeger Christopher A.Director · Chief Executive Officer
|
SaleVoting Common Stock | 5,427 | $28.37 | $153,963.99 |
DisclosureSEC source: 0001658918-26-000008 · form4-05062026_080501.xml · nonDerivative · entry 2 Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,616,001 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.845 to $28.73 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 04, 2026 Filed May 7, 2026 00:15 UTC |
Kroeger Christopher A.Director · Chief Executive Officer
|
SaleVoting Common Stock | 9,136 | $27.50 | $251,240.00 |
DisclosureSEC source: 0001658918-26-000008 · form4-05062026_080501.xml · nonDerivative · entry 1 Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,621,428 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.84 to $27.835 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 04, 2026 Filed May 7, 2026 00:15 UTC |
Lillie James WoodruffChief Scientific Officer
|
SaleVoting Common Stock | 705 | $30.08 | $21,206.40 |
DisclosureSEC source: 0001728746-26-000008 · form4-05062026_080505.xml · nonDerivative · entry 4 Lillie James Woodruff · CIK 0001728746 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 279,356 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.55 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 04, 2026 Filed May 7, 2026 00:15 UTC |
Lillie James WoodruffChief Scientific Officer
|
SaleVoting Common Stock | 320 | $29.56 | $9,459.20 |
DisclosureSEC source: 0001728746-26-000008 · form4-05062026_080505.xml · nonDerivative · entry 3 Lillie James Woodruff · CIK 0001728746 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 280,061 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.9669 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 04, 2026 Filed May 7, 2026 00:15 UTC |
Lillie James WoodruffChief Scientific Officer
|
SaleVoting Common Stock | 5,526 | $28.37 | $156,772.62 |
DisclosureSEC source: 0001728746-26-000008 · form4-05062026_080505.xml · nonDerivative · entry 2 Lillie James Woodruff · CIK 0001728746 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 280,381 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.845 to $28.74 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 04, 2026 Filed May 7, 2026 00:15 UTC |
Lillie James WoodruffChief Scientific Officer
|
SaleVoting Common Stock | 9,250 | $27.50 | $254,375.00 |
DisclosureSEC source: 0001728746-26-000008 · form4-05062026_080505.xml · nonDerivative · entry 1 Lillie James Woodruff · CIK 0001728746 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 285,907 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.84 to $27.835 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 04, 2026 Filed May 7, 2026 00:15 UTC |
Hanson KristopherGeneral Counsel
|
SaleVoting Common Stock | 683 | $30.08 | $20,544.64 |
DisclosureSEC source: 0001789970-26-000008 · form4-05062026_080503.xml · nonDerivative · entry 4 Hanson Kristopher · CIK 0001789970 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 176,248 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.55 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 04, 2026 Filed May 7, 2026 00:15 UTC |
Hanson KristopherGeneral Counsel
|
SaleVoting Common Stock | 296 | $29.56 | $8,749.76 |
DisclosureSEC source: 0001789970-26-000008 · form4-05062026_080503.xml · nonDerivative · entry 3 Hanson Kristopher · CIK 0001789970 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 176,931 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.9669 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 04, 2026 Filed May 7, 2026 00:15 UTC |
Hanson KristopherGeneral Counsel
|
SaleVoting Common Stock | 3,908 | $28.29 | $110,557.32 |
DisclosureSEC source: 0001789970-26-000008 · form4-05062026_080503.xml · nonDerivative · entry 2 Hanson Kristopher · CIK 0001789970 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 177,227 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.845 to $28.73 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 04, 2026 Filed May 7, 2026 00:15 UTC |
Hanson KristopherGeneral Counsel
|
SaleVoting Common Stock | 9,030 | $27.50 | $248,325.00 |
DisclosureSEC source: 0001789970-26-000008 · form4-05062026_080503.xml · nonDerivative · entry 1 Hanson Kristopher · CIK 0001789970 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 181,135 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.84 to $27.835 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 28, 2026 Filed Apr 29, 2026 20:30 UTC |
GILLIS JONATHANCAAO and PAO
|
SaleVoting Common Stock | 700 | $30.83 | $21,581.00 |
DisclosureSEC source: 0001709954-26-000008 · form4-04292026_040431.xml · nonDerivative · entry 5 GILLIS JONATHAN · CIK 0001709954 · CAAO and PAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 181,219 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.81 to $30.86 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 28, 2026 Filed Apr 29, 2026 20:30 UTC |
GILLIS JONATHANCAAO and PAO
|
SaleVoting Common Stock | 17,235 | $30.33 | $522,737.55 |
DisclosureSEC source: 0001709954-26-000008 · form4-04292026_040431.xml · nonDerivative · entry 4 GILLIS JONATHAN · CIK 0001709954 · CAAO and PAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 181,919 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.755 to $30.71 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 27, 2026 Filed Apr 29, 2026 20:30 UTC |
Kreitzer AnatolChief Discovery Officer
|
SaleVoting Common Stock | 7,821 | $30.50 | $238,540.50 |
DisclosureSEC source: 0002021238-26-000008 · form4-04292026_040429.xml · nonDerivative · entry 3 Kreitzer Anatol · CIK 0002021238 · Chief Discovery Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 211,190 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 24, 2025. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.27 to $30.64 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 27, 2026 Filed Apr 29, 2026 20:30 UTC |
Kreitzer AnatolChief Discovery Officer
|
SaleVoting Common Stock | 29,255 | $29.63 | $866,825.65 |
DisclosureSEC source: 0002021238-26-000008 · form4-04292026_040429.xml · nonDerivative · entry 2 Kreitzer Anatol · CIK 0002021238 · Chief Discovery Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 219,011 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 24, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.27 to $30.26 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 27, 2026 Filed Apr 29, 2026 20:30 UTC |
Kreitzer AnatolChief Discovery Officer
|
SaleVoting Common Stock | 8,346 | $28.96 | $241,700.16 |
DisclosureSEC source: 0002021238-26-000008 · form4-04292026_040429.xml · nonDerivative · entry 1 Kreitzer Anatol · CIK 0002021238 · Chief Discovery Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 248,266 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 24, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.27 to $29.26 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 27, 2026 Filed Apr 29, 2026 20:30 UTC |
GILLIS JONATHANCAAO and PAO
|
SaleVoting Common Stock | 14,363 | $30.46 | $437,496.98 |
DisclosureSEC source: 0001709954-26-000008 · form4-04292026_040431.xml · nonDerivative · entry 3 GILLIS JONATHAN · CIK 0001709954 · CAAO and PAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 199,154 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.27 to $30.64 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 27, 2026 Filed Apr 29, 2026 20:30 UTC |
GILLIS JONATHANCAAO and PAO
|
SaleVoting Common Stock | 29,623 | $29.60 | $876,840.80 |
DisclosureSEC source: 0001709954-26-000008 · form4-04292026_040431.xml · nonDerivative · entry 2 GILLIS JONATHAN · CIK 0001709954 · CAAO and PAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 213,517 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.27 to $30.25 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 27, 2026 Filed Apr 29, 2026 20:30 UTC |
GILLIS JONATHANCAAO and PAO
|
SaleVoting Common Stock | 7,914 | $28.94 | $229,031.16 |
DisclosureSEC source: 0001709954-26-000008 · form4-04292026_040431.xml · nonDerivative · entry 1 GILLIS JONATHAN · CIK 0001709954 · CAAO and PAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 243,140 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.27 to $29.25 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 16, 2026 Filed Apr 17, 2026 20:05 UTC |
Setia VishwasChief Financial Officer
|
SaleVoting Common Stock | 87 | $27.49 | $2,391.63 |
DisclosureSEC source: 0002021256-26-000006 · form4-04172026_040410.xml · nonDerivative · entry 3 Setia Vishwas · CIK 0002021256 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 392,627 F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.22 to $27.9898 inclusive. Read SEC document |
| April 16, 2026 Filed Apr 17, 2026 20:05 UTC |
Setia VishwasChief Financial Officer
|
SaleVoting Common Stock | 29 | $27.01 | $783.29 |
DisclosureSEC source: 0002021256-26-000006 · form4-04172026_040410.xml · nonDerivative · entry 2 Setia Vishwas · CIK 0002021256 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 392,714 F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.2201 to $27.2197 inclusive. Read SEC document |
| April 16, 2026 Filed Apr 17, 2026 20:05 UTC |
Foff Erin PennockChief Medical Officer
|
SaleVoting Common Stock | 881 | $27.49 | $24,218.69 |
DisclosureSEC source: 0002021233-26-000006 · form4-04172026_040406.xml · nonDerivative · entry 3 Foff Erin Pennock · CIK 0002021233 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,777 F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.22 to $27.9898 inclusive. Read SEC document |
| April 16, 2026 Filed Apr 17, 2026 20:05 UTC |
Foff Erin PennockChief Medical Officer
|
SaleVoting Common Stock | 288 | $27.01 | $7,778.88 |
DisclosureSEC source: 0002021233-26-000006 · form4-04172026_040406.xml · nonDerivative · entry 2 Foff Erin Pennock · CIK 0002021233 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 401,658 F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.2201 to $27.2197 inclusive. Read SEC document |
| April 16, 2026 Filed Apr 17, 2026 20:05 UTC |
Kroeger Christopher A.Director · Chief Executive Officer
|
SaleVoting Common Stock | 7,575 | $27.49 | $208,236.75 |
DisclosureSEC source: 0001658918-26-000006 · form4-04172026_040404.xml · nonDerivative · entry 3 Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,630,564 F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.22 to $27.9898 inclusive. Read SEC document |
| April 16, 2026 Filed Apr 17, 2026 20:05 UTC |
Kroeger Christopher A.Director · Chief Executive Officer
|
SaleVoting Common Stock | 2,477 | $27.01 | $66,903.77 |
DisclosureSEC source: 0001658918-26-000006 · form4-04172026_040404.xml · nonDerivative · entry 2 Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,638,139 F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.2201 to $27.2197 inclusive. Read SEC document |
| April 16, 2026 Filed Apr 17, 2026 20:05 UTC |
Lillie James WoodruffChief Scientific Officer
|
SaleVoting Common Stock | 2,097 | $27.49 | $57,646.53 |
DisclosureSEC source: 0001728746-26-000006 · form4-04172026_040408.xml · nonDerivative · entry 3 Lillie James Woodruff · CIK 0001728746 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 295,157 F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.22 to $27.9898 inclusive. Read SEC document |
| April 16, 2026 Filed Apr 17, 2026 20:05 UTC |
Lillie James WoodruffChief Scientific Officer
|
SaleVoting Common Stock | 686 | $27.01 | $18,528.86 |
DisclosureSEC source: 0001728746-26-000006 · form4-04172026_040408.xml · nonDerivative · entry 2 Lillie James Woodruff · CIK 0001728746 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 297,254 F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.2201 to $27.2197 inclusive. Read SEC document |
| April 16, 2026 Filed Apr 17, 2026 20:05 UTC |
Hanson KristopherGeneral Counsel
|
SaleVoting Common Stock | 225 | $27.49 | $6,185.25 |
DisclosureSEC source: 0001789970-26-000006 · form4-04172026_040411.xml · nonDerivative · entry 3 Hanson Kristopher · CIK 0001789970 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 190,165 F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.22 to $27.9898 inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.